Literature DB >> 19859701

The regional distribution of T2-relaxation times in MR images of the substantia nigra and crus cerebri.

Constantin Mänz1, Jana Godau, Daniela Berg, Benjamin Bender, Ulrike Ernemann, Uwe Klose.   

Abstract

INTRODUCTION: When scanning the size of the substantia nigra (SN), for example in Parkinson's disease, it is important to precisely locate its true anatomic location. The hypointense areas on T2-weighted magnetic resonance images (T2w) at the level of the upper midbrain are usually labeled as the SN. Recent studies showed that the line of demarcation between the SN and the crus cerebri (CC) in T2w images seems not to be clear. The purpose of our study was to evaluate the depiction of the SN and the CC on calculated R2 maps by analyzing the regional distribution of T2 values in both regions.
METHODS: In 36 healthy subjects, triple echo turbo spin echo were obtained at 1.5 T and R2 maps calculated. Proton density-weighted turbo spin echo images (PDw) were used as reference. The CC and SN were manually traced on PDw sections (CCP and SNP) and also the hyperintense areas on the R2 maps, suggestive of the SN (DT2). The obtained volumes were evaluated in terms of total size, intersections size, and residual areas, as well as the corresponding T2 values.
RESULTS: DT2 corresponded to anterolateral parts of the SNP and showed an extension to anteromedial part of the CC. The intersections between DT2 and CCP and DT2 and SNP presented both decreased but different T2 values (102 +/- 5 and 95 +/- 4 ms).
CONCLUSION: An exact differentiation of the SN from the CC is not possible on the basis of T2w images but rather on the basis of the underlying calculated T2 values from the triple echo sequence.

Entities:  

Mesh:

Year:  2009        PMID: 19859701     DOI: 10.1007/s00234-009-0612-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  23 in total

1.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content.

Authors:  J Vymazal; A Righini; R A Brooks; M Canesi; C Mariani; M Leonardi; G Pezzoli
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

Review 2.  Imaging iron stores in the brain using magnetic resonance imaging.

Authors:  E Mark Haacke; Norman Y C Cheng; Michael J House; Qiang Liu; Jaladhar Neelavalli; Robert J Ogg; Asadullah Khan; Muhammad Ayaz; Wolff Kirsch; Andre Obenaus
Journal:  Magn Reson Imaging       Date:  2005-01       Impact factor: 2.546

3.  Magnetic resonance imaging of the brainstem and cranial nerves.

Authors:  R Lufkin; B D Flannigan; J R Bentson; G H Wilson; W Rauschning; W Hanafee
Journal:  Surg Radiol Anat       Date:  1986       Impact factor: 1.246

4.  MRI of brain iron.

Authors:  B Drayer; P Burger; R Darwin; S Riederer; R Herfkens; G A Johnson
Journal:  AJR Am J Roentgenol       Date:  1986-07       Impact factor: 3.959

5.  Magnetic resonance imaging of the midbrain in Parkinson's disease.

Authors:  J R Duguid; R De La Paz; J DeGroot
Journal:  Ann Neurol       Date:  1986-12       Impact factor: 10.422

6.  MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

Authors:  G Bartzokis; J L Cummings; C H Markham; P Z Marmarelis; L J Treciokas; T A Tishler; S R Marder; J Mintz
Journal:  Magn Reson Imaging       Date:  1999-02       Impact factor: 2.546

Review 7.  Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications.

Authors:  Makoto Sasaki; Eri Shibata; Koujiro Tohyama; Kohsuke Kudo; Jin Endoh; Kotaro Otsuka; Akio Sakai
Journal:  Neuroreport       Date:  2008-11-19       Impact factor: 1.837

8.  T2 relaxation time in patients with Parkinson's disease.

Authors:  A Antonini; K L Leenders; D Meier; W H Oertel; P Boesiger; M Anliker
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

9.  MRI assessment of basal ganglia iron deposition in Parkinson's disease.

Authors:  Lauren I Wallis; Martyn N J Paley; Jacqueline M Graham; Richard A Grünewald; Emma L Wignall; Harriet M Joy; Paul D Griffiths
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

10.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682

View more
  2 in total

1.  Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology.

Authors:  Mark S Bolding; Meredith A Reid; Kathy B Avsar; Rosalinda C Roberts; Paul D Gamlin; Timothy J Gawne; David M White; Jan A den Hollander; Adrienne C Lahti
Journal:  Biol Psychiatry       Date:  2012-09-12       Impact factor: 13.382

2.  The Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRI.

Authors:  Jae-Hyeok Lee; Sun-Yong Baek; YoungKyu Song; Sujeong Lim; Hansol Lee; Minh Phuong Nguyen; Eun-Joo Kim; Gi Yeong Huh; Se Young Chun; HyungJoon Cho
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.